Bionics Market to Reach $64 Billion by 2035

Bionics market was valued at $26.5 billion in 2025 and is projected to reach $64.0 billion by 2035, growing at a CAGR of 9.2% during the forecast period (2026-2035). The rising prevalence of disabilities, neurological disorders, and mobility impairments is significantly driving demand for advanced bionic devices across healthcare systems. Bionic technologies, including prosthetic limbs, neural implants, cochlear devices, and exoskeleton systems, play a critical role in restoring physical functions, improving patient mobility, and enhancing quality of life. The increasing integration of artificial intelligence and microprocessor-controlled systems is further strengthening product efficiency, precision, and adaptability in real-time clinical applications. Hospitals and rehabilitation centres remain the primary demand contributors, supported by increasing surgical procedures and post-operative rehabilitation requirements.

Browse the full report description of “Bionics Market Size, Share & Trends Analysis Report, By Product Type (Orthopaedic Bionics, Cardiac Bionics, Neural / Brain Bionics, Sensory Bionics, Exoskeleton Systems), By Technology Platform (Mechanical, Electromechanical, Microprocessor-Controlled, AI-Integrated), By End-User (Hospitals & Surgical Centers, Rehabilitation Centers, Homecare Settings, Military & Defense), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/bionics-market-share

According to the World Health Organisation (WHO), over 2.5 billion people globally require assistive products, with this number expected to reach 3.5 billion by 2050, highlighting strong long-term demand for bionic solutions. Additionally, the WHO estimates that 1.3 billion people live with significant disability, reinforcing the need for advanced assistive technologies such as orthopaedic prosthetics, neural interfaces, and sensory implants. These trends are accelerating the adoption of bionic devices across both developed and emerging healthcare markets. Regulatory approvals and technological advancements are further supporting market expansion. The U.S. Food and Drug Administration (FDA) continues to approve innovative implantable and neuromodulation devices, enabling faster commercialisation of next-generation bionic solutions. Additionally, advancements in digital health and connected medical technologies, supported by the International Telecommunication Union (ITU), are improving integration between hardware and software systems, enabling real-time monitoring and adaptive functionality in smart bionic devices. The growing use of exoskeleton systems in military and defence applications is also contributing to market growth, driven by increasing investments in soldier mobility and rehabilitation technologies.

Key Leaders Transforming the Bionics Market

The key players in the bionics market include Ottobock SE & Co. KGaA, Össur hf., Ekso Bionics, Cyberdyne Inc., and Palladyne AI Corp., among others. These companies are focusing on product innovation, AI integration, and the expansion of rehabilitation-focused technologies to strengthen their market position.

• In March 2026, Lifeward announced a landmark collaboration with the top-ranked rehabilitation hospital, Shirley Ryan AbilityLab. The partnership will launch dedicated clinical trial and evaluation days in Q2 2026 at the hospital's Chicago campus to accelerate patient evaluation and access to the FDA-cleared ReWalk Personal Exoskeleton for individuals with spinal cord injuries.
• In December 2025, Lifeward secured an exclusive international distribution agreement with Singapore-based Verita Neuro. This deal expanded the reach of the ReWalk Personal Exoskeleton into Mexico, Thailand, and the United Arab Emirates, integrating the robotic exoskeleton into intensive, in-patient neurorehabilitation programs.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Product Type
  • Technology Platform
  • End-User
  • Component
  • Material Type
  • Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – Ottobock SE & Co. KGaA, Össur hf., Ekso Bionics, Cyberdyne Inc., Palladyne AI Corp., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Bionics Market Report Segment

By Product Type

• Orthopaedic Bionics
  • Cardiac Bionics
  • Neural / Brain Bionics
  • Sensory Bionics
  • Exoskeleton Systems

By Technology Platform

• Mechanical Bionics
  • Electromechanical Bionics
  • Microprocessor-Controlled Systems
  • AI-Integrated / Smart Bionics

By End-User

• Hospitals & Surgical Centers
  • Rehabilitation Centers
  • Homecare Settings
  • Military & Defense

By Component

• Hardware
  • Software & Control Systems
  • Accessories & Consumables

By Material Type

• Metal-Based
  • Polymer-Based
  • Composite Materials

Global Bionics Market Report Segment by Region

North America

• United States
  • Canada

Europe

• UK
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe

Asia-Pacific

• China
  • India
  • Japan
  • South Korea
  • Australia and New Zealand
  • ASEAN Economies
  • Rest of Asia-Pacific

Rest of the World

• Latin America
  • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bionics-market-share